# Senti Biosciences Holdings, Inc.: Form 8-K, filed Oct 26, 2026

- Company: [Senti Biosciences Holdings, Inc.](/companies/snti.md) (CIK 1854270)
- Form: 8-K
- Filed: 2026-10-26
- Accepted by EDGAR: Oct 26, 2026, 16:17 ET
- Period: 2026-10-21
- Accession: 0001140361-26-040772
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1854270/000114036126040772/ef20084208_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1854270/000114036126040772/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1854270/000114036126040772/ef20084208_8k.htm

Filed Oct 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-040772. Last ingested by Listed: Oct 27, 2026, 16:38 ET. No prices; not investment advice.